Acute chest pain (ACP) is a common symptom that can indicate a range of conditions, from benign to life-threatening. The clinical approach to ACP requires a thorough understanding of differential diagnoses, relevant investigations, and appropriate management strategies.
The initial assessment of a patient presenting with ACP should focus on identifying immediate life-threatening conditions such as myocardial infarction (MI) or aortic dissection. Vital signs, physical examination, and a 12-lead ECG should be performed rapidly. The patient's history, including the characteristics of the pain and risk factors for coronary artery disease, can provide valuable diagnostic clues.
ACP can arise from cardiac, gastrointestinal, pulmonary, musculoskeletal, and psychiatric conditions. Cardiac causes include MI, angina, and pericarditis. Gastrointestinal conditions such as gastroesophageal reflux disease and peptic ulcer disease can mimic cardiac pain. Pulmonary causes include pulmonary embolism and pneumonia. Musculoskeletal and psychiatric causes are often considered once life-threatening conditions have been ruled out.
Investigations should be guided by the suspected diagnosis. For suspected MI, cardiac biomarkers (troponin) and repeated ECGs are essential. Chest radiography, computed tomography, and endoscopy may be indicated for pulmonary and gastrointestinal causes, respectively.
Management depends on the underlying cause. Immediate reperfusion therapy is critical in MI, while aortic dissection requires surgical intervention. Gastrointestinal, pulmonary, musculoskeletal, and psychiatric causes are managed according to their specific treatment guidelines.
The clinical approach to ACP is challenging due to the wide range of potential causes. A systematic approach, guided by a thorough history, physical examination, and appropriate investigations, can help healthcare professionals accurately diagnose and manage these patients. Ongoing education and training in this area are crucial to ensure the best patient outcomes.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation